{"disease":{"id":"early-glottic-cancer","name":"early glottic cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07197060","title":"Hypofractionated Radiotherapy With 3.5 Gy Per Fraction for Early Glottic Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":70,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT01984502","title":"CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}